Informações:
Falhas:
ID
16766
Descrição
Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00133913
Link
https://clinicaltrials.gov/show/NCT00133913
Palavras-chave
Versões (1)
- 05/08/2016 05/08/2016 -
Transferido a
5 de agosto de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Colorectal Cancer NCT00133913
Eligibility Colorectal Cancer NCT00133913
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT00133913
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Malignant neoplasm of colon stage IV Measurable | Secondary malignant neoplasm of rectum Measurable
Item
measurable metastatic carcinoma of the colon or rectum.
boolean
C0278484 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C0346975 (UMLS CUI [2,1])
C1513040 (UMLS CUI [2,2])
C1513040 (UMLS CUI [1,2])
C0346975 (UMLS CUI [2,1])
C1513040 (UMLS CUI [2,2])
Chemotherapy First line treatment | Chemotherapy Second line treatment | Chemotherapy Third line treatment | Therapeutic procedure Targeted Epidermal Growth Factor Receptor
Item
1st or 2nd line chemotherapy (3rd line acceptable with epidermal growth factor receptor [egfr] targeted therapy)
boolean
C0392920 (UMLS CUI [1,1])
C1708063 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C1710038 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C2986605 (UMLS CUI [3,2])
C0087111 (UMLS CUI [4,1])
C1521840 (UMLS CUI [4,2])
C0034802 (UMLS CUI [4,3])
C1708063 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C1710038 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C2986605 (UMLS CUI [3,2])
C0087111 (UMLS CUI [4,1])
C1521840 (UMLS CUI [4,2])
C0034802 (UMLS CUI [4,3])
Chest scan | Abdomen scan | Computed Tomography (CT) of Pelvis
Item
chest/abdomen/pelvis scans every 6-12 weeks
boolean
C3888834 (UMLS CUI [1])
C0860675 (UMLS CUI [2])
C0412628 (UMLS CUI [3])
C0860675 (UMLS CUI [2])
C0412628 (UMLS CUI [3])
ECOG performance status
Item
ecog 0-2
boolean
C1520224 (UMLS CUI [1])
Hemoglobin
Item
hemoglobin (hgb) > or = 8g/dl within 7 days prior to enrollment
boolean
C0019046 (UMLS CUI [1])
Age
Item
age > or = to 18 years of age
boolean
C0001779 (UMLS CUI [1])
Blood draw Weekly Cumulative
Item
cumulative weekly blood draws exceeding 150ml/week
boolean
C0005834 (UMLS CUI [1,1])
C0332174 (UMLS CUI [1,2])
C1511559 (UMLS CUI [1,3])
C0332174 (UMLS CUI [1,2])
C1511559 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain
Item
brain metastasis
boolean
C0220650 (UMLS CUI [1])
Carcinoma | Noninfiltrating Intraductal Carcinoma | cervical cancer Non-invasive | Skin carcinoma
Item
prior history of other carcinoma within the last 5 years, except ductal carcinoma in situ (dcis), non-invasive cervical cancer or non-melanoma skin cancer
boolean
C0007097 (UMLS CUI [1])
C0007124 (UMLS CUI [2])
C4048328 (UMLS CUI [3,1])
C0205303 (UMLS CUI [3,2])
C0699893 (UMLS CUI [4])
C0007124 (UMLS CUI [2])
C4048328 (UMLS CUI [3,1])
C0205303 (UMLS CUI [3,2])
C0699893 (UMLS CUI [4])
Operative Surgical Procedures | Blood draw Initially | Insertion of Central Venous Access Device
Item
surgery within 14 days of the initial blood draw, excluding surgical placement of a central venous device
boolean
C0543467 (UMLS CUI [1])
C0005834 (UMLS CUI [2,1])
C0205265 (UMLS CUI [2,2])
C1610121 (UMLS CUI [3])
C0005834 (UMLS CUI [2,1])
C0205265 (UMLS CUI [2,2])
C1610121 (UMLS CUI [3])